Ever since December of 2014, Cannabis has made some amazing strides in the United States. From solely being a Schedule 1 Drug, to having a form of Cannabis (industrial hemp) removed from the CSA all together.

What’s been driving the growth? Our favorite non-psychoactive cannabinoid, CBD, of course.

CBD has been found to have a ton of medicinal value (though don’t let the FDA hear you say that out loud). It doesn’t get you high, it’s effects are wide spread, and people from every walk of life are falling in love with CBD.

Digging Deeper Into Cannabis

While CBD deserves it’s place in the spotlight, and we are confident that CBD will have a place in our homes for a long, long time, we are just scratching the surface of what cannabis has to offer.

We aren’t talking about THC, either. While the limited amounts of THC in industrial hemp (0.3% or less) certainly has an impact, there are at least 113 cannabinoids in cannabis. To think that THC and CBD are the only two that have value is short sighted.

The Industry Is Catching On

While this year we have seen exponential growth in the production of high CBD hemp, there is another crop being grown that is just about to hit the market: CBG.

CBG has been on the radar of those deep in genetics for a little while now, but this season was the first to see more than just experimental or beta grows. Several genetics producers launched quiet, or even secret, CBG programs that are just now being harvested, and early indicators are showing the pricing of CBG biomass, flower, and extracts are reminiscent of the first year of CBD production.

What is CBG?

CBG, or cannabigerol, is a cannabinoid like CBD and THC. It’s reported to have “anti-fungal, anti-insect and anti-inflammatory activity; neuroprotective activity; stimulation of appetite, and enhancement of the death process of cancer cell.” Anecdotally, these effects seem to be confirmed by those early users fortunate enough to get their hands on some.

Where Can You Get CBG Products?

In response to the industry, we’ve recently made an update to the software that now allows users to select which is the primary cannabinoid for their product. Instead of just assuming everything is CBD-centric, you can now see if a product is marked as CBD or CBG (not to mention CBC, CBN, or THCV). In addition, if you are a buyer, you can filter listing by primary cannabinoid and see only CBG listings.

We are excited about CBG, and you should be, too. Even more exciting is what CBG represents: a new sunset after the dawn of the CBD empire, with promise of more cannabinoid popularity in the future.